Jennifer Brainard

Cleveland Clinic

Papers

1

Total Citations

76

H-Index

1

About

Dr. Jennifer Brainard is a pioneering researcher in the field of minimally invasive oncologic interventions, with a primary focus on the application of advanced stereotactic radiosurgery technologies for extracorporeal tissue ablation. Her most cited work, the 2003 study "Initial evaluation of cyberknife technology for extracorporeal renal tissue ablation" (76 citations), established a foundational framework for using robotic radiosurgery in non-cranial sites, demonstrating the feasibility and precision of delivering high-dose radiation to renal tumors while sparing surrounding healthy tissue. This contribution was instrumental in expanding the clinical utility of the CyberKnife system beyond brain and spine lesions, opening new avenues for treating kidney and other abdominal cancers without invasive surgery. Dr. Brainard’s research has been widely recognized for bridging engineering and clinical oncology, influencing subsequent trials in stereotactic body radiotherapy (SBRT). Her work continues to shape protocols for image-guided ablation, highlighting her role as a key figure in the evolution of non-invasive cancer therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
76
Total Citations
76
Avg Citations/Paper
🏆 Most Cited Paper
Initial evaluation of cyberknife technology for extracorporeal renal tissue ablation
76 citations · 2003
📈 Most Prolific Year: 2003 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago